行情

TARO

TARO

Taro Pharm
NYSE

实时行情|Nasdaq Last Sale

75.71
-0.32
-0.42%
盘后: 75.71 0 0.00% 16:00 10/18 EDT
开盘
75.55
昨收
76.03
最高
76.70
最低
75.29
成交量
3.73万
成交额
--
52周最高
109.42
52周最低
72.97
市值
29.18亿
市盈率(TTM)
10.47
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TARO 新闻

  • Does Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Have A Good P/E Ratio?
  • Simply Wall St..3天前
  • Stealth BioTherapeutics Does The Deal With Alexion, And Other Headlines: The Good, Bad And Ugly Of Biopharma
  • Seeking Alpha - Article.5天前
  • Aclaris sues Taro Pharma for patent infringement
  • seekingalpha.10/09 16:39
  • The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
  • Benzinga.10/09 12:58

更多

所属板块

制药
-0.90%
制药与医学研究
-0.94%

热门股票

名称
价格
涨跌幅

TARO 简况

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
展开

Webull提供Taro Pharmaceutical Industries Ltd.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。